XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING ACTIVITIES:    
Net income (loss) $ (11,073) $ (21,648)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 13,539 11,592
Net amortization of deferred financing costs (net of original issue discount and debt premium) 1,002 193
Net deferred taxes (benefit) and other (4,039) (534)
Provision for bad debts 49 346
Net (gain) loss on sale or disposal (2,458) (2)
Non-cash stock-based compensation expense 2,698 2,578
Net loss on extinguishment of debt 0 8,168
Deferred compensation (1,725) 1,263
Impairment loss 1,521 644
Change in fair value of contingent consideration 282 0
Changes in assets and liabilities (net of effects of acquisitions, and dispositions):    
Accounts receivable 48,135 66,511
Prepaid expenses and deposits (18,574) (21,732)
Accounts payable and accrued liabilities (9,202) (1,018)
Other assets 0 (324)
Accrued interest expense (1,454) 2,598
Accrued liabilities - long-term (3,481) (4,781)
Net cash provided by (used in) operating activities 15,220 43,854
INVESTING ACTIVITIES:    
Additions to property, equipment and software (14,522) (7,280)
Proceeds from sale of property, equipment, intangibles and other assets 2,464 0
Purchases of businesses and audio assets 0 (15,297)
Net cash provided by (used in) investing activities (12,058) (22,577)
FINANCING ACTIVITIES:    
Borrowing under the revolving senior debt 0 12,000
Proceeds from issuance of long-term debt 0 540,000
Payments of long-term debt 0 (77,015)
Payments of revolving senior debt (22,727) (52,000)
Retirement of notes 0 (400,000)
Payment for debt issuance costs 0 (6,914)
Payment of call premium and other fees 0 (14,500)
Proceeds from issuance of employee stock plan 177 0
Proceeds from the exercise of stock options 0 15
Purchase of vested employee restricted stock units (1,839) (1,911)
Payment of dividend equivalents on vested restricted stock units (174) (386)
Net cash provided by (used in) financing activities (24,563) (711)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (21,401) 20,566
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 59,439 30,964
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD 38,038 51,530
Cash paid (received) during the period for:    
Interest 23,616 18,506
Income taxes $ (15,201) $ (493)